Bladder Cancer Clinical Trial

The Personal Patient Profile Decision Support for Patients With Bladder Cancer

Summary

There is a pressing need to develop a personalized, value-based decisional tool for bladder cancer patients undergoing radical cystectomy (bladder removal) and urinary diversion to help them with communication with the physicians, shared decision making, and preparation for disease-management and follow-up care. The proposed intervention, the Personal Patient Profile - Bladder Cancer (P3-BC), will be the first intervention to address these issues. Results of this pilot randomized feasibility study will provide evidence of the feasibility and acceptability of the P3-BC and will guide further refinement of the tool for a larger experimental trial, with potential dissemination of the program via the Internet and hand-held computing devices.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients: cystectomy for MIBC and NMIBC;
at least 18 years;
able to communicate in English; and
competent to give consent.

Exclusion Criteria:

- Existence of other cancers or ongoing cancer treatment.

Study is for people with:

Bladder Cancer

Estimated Enrollment:

21

Study ID:

NCT05033067

Recruitment Status:

Recruiting

Sponsor:

Icahn School of Medicine at Mount Sinai

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Icahn School of Medicine at Mount Sinai
New York New York, 10029, United States More Info
Nihal Mohammed, PhD
Principal Investigator
University of Washington
Seattle Washington, 98195, United States

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

21

Study ID:

NCT05033067

Recruitment Status:

Recruiting

Sponsor:


Icahn School of Medicine at Mount Sinai

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.